{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:33:50Z","timestamp":1790361230162,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Trials may pause antiretroviral treatment to study HIV remission, but little is known about the perspectives of people living with HIV in highly prevalent regions. This mixed methods study qualitatively explored perspectives and quantitatively measured research participation willingness. Using snowball sampling, we included consenting adults with HIV in Soweto, South Africa. Of 100 people who completed questionnaires of demographics and participation willingness, 49 without analytic treatment interruption experience participated in 1 of 5 stratified focus groups, and 1 with analytic treatment interruption experience participated in an individual interview. We conducted the study at a research facility during 2024. The analyst performed manual inductive coding on transcripts from audio-recordings and analyzed thematically. We summarized quantitative data using descriptive statistics, compared groups using the Kruskal-Wallis test and assessed factors associated with willingness using univariate and multivariate logistic regression. Of 100 participants (44% female, median age 39 years) surveyed, 96% were willing to participate in HIV cure research, varying by study procedure: 75% if antiretrovirals paused, 97% if blood collected, 57% if lymph nodes, 41% if gut, and 39% if cerebrospinal fluid sampled. Willingness to pause antiretrovirals was similar for people aged 40+ versus 18\u201339 years (p\u2009=\u20090.248), antiretroviral duration 1\u20138 versus 9\u2009+\u2009years (p\u2009=\u20090.759) and females versus males (p\u2009=\u20090.740). Prior cure research participation increased willingness to pause antiretrovirals (RR: 1.36, 95% CI: 1.17-1.58). The focus groups (n\u2009=\u200949) and interview (n\u2009=\u20091) revealed themes about pausing HIV treatment: physical and emotional health considerations, social considerations including non-adherence stigma and selective conditional disclosure, lifestyle optimization and healthcare interactions. Recommendations for researchers conducting analytic treatment interruption trials in South Africa include: counselling about monitoring, lifestyle health and treatment re-initiation; offering disclosure support; communicating directly with antiretroviral clinics about treatment pauses; and minimising mandatory invasive procedures. Negative healthcare experiences suggest treatment programmes should address staff burnout.<\/jats:p>","DOI":"10.1371\/journal.pgph.0004425","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:38:21Z","timestamp":1762454301000},"page":"e0004425","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antiretroviral pause for HIV remission trials: A mixed methods study of people living with HIV in Soweto, South Africa"],"prefix":"10.1371","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5231-9951","authenticated-orcid":true,"given":"Fatima","family":"Laher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbalenhle","family":"Sibiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naledi","family":"Mahlangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Otwombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"8","key":"pgph.0004425.ref001","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00018-022-04421-z","article-title":"HIV cure strategies: which ones are appropriate for Africa?","volume":"79","author":"CZ-Y Abana","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"pgph.0004425.ref002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S2055-6640(20)30275-2","article-title":"Establishment of latent HIV-1 reservoirs: what do we really know?","volume":"5","author":"J Vanhamel","year":"2019","journal-title":"J Virus Erad"},{"issue":"2","key":"pgph.0004425.ref003","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1172\/JCI80563","article-title":"Hematopoietic stem cell transplantation for HIV cure","volume":"126","author":"DR Kuritzkes","year":"2016","journal-title":"J Clin Invest"},{"issue":"4","key":"pgph.0004425.ref004","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.jve.2020.100010","article-title":"A landscape analysis of HIV cure-related clinical research in 2019","volume":"6","author":"L Barr","year":"2020","journal-title":"J Virus Erad"},{"issue":"1","key":"pgph.0004425.ref005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41467-019-08311-0","article-title":"A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation","volume":"10","author":"A Violari","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"pgph.0004425.ref006","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QAD.0000000000002044","article-title":"Virological remission after antiretroviral therapy interruption in female African HIV seroconverters","volume":"33","author":"M Gossez","year":"2019","journal-title":"AIDS"},{"issue":"1","key":"pgph.0004425.ref007","doi-asserted-by":"crossref","first-page":"2267825","DOI":"10.1080\/25787489.2023.2267825","article-title":"Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States","volume":"24","author":"A Bilger","year":"2023","journal-title":"HIV Res Clin Pract"},{"issue":"8","key":"pgph.0004425.ref008","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/aid.2021.0192","article-title":"Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings","volume":"38","author":"P Saberi","year":"2022","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"pgph.0004425.ref009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2055-6640(20)30009-1","article-title":"A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption","volume":"6","author":"MJ Peluso","year":"2020","journal-title":"J Virus Erad"},{"issue":"7","key":"pgph.0004425.ref010","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/v13071403","article-title":"Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot Study","volume":"13","author":"R Scutari","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"pgph.0004425.ref011","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/cid\/ciz417","article-title":"Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure Trials","volume":"70","author":"M Stecher","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pgph.0004425.ref012","article-title":"The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysis","volume":"27","author":"MJ Lee","year":"2024","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"pgph.0004425.ref013","article-title":"Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults","author":"NP Pai","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"pgph.0004425.ref014","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/QAD.0000000000002113","article-title":"Clinical trials of antiretroviral treatment interruption in HIV-infected individuals","volume":"33","author":"JSY Lau","year":"2019","journal-title":"AIDS"},{"issue":"6","key":"pgph.0004425.ref015","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26495","article-title":"Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data","volume":"28","author":"S Karuna","year":"2025","journal-title":"J Int AIDS Soc"},{"key":"pgph.0004425.ref016","unstructured":"HIV Prevention Trials Network. [Internet]. HPTN protocols snapshot. 2024 Jul [cited 2025 Feb 27]. Available from: https:\/\/www.hptn.org\/sites\/default\/files\/inlinefiles\/HPTN%20Protocols%20Snapshot_July%202024.pdf"},{"issue":"7","key":"pgph.0004425.ref017","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/v16071163","article-title":"HIV Persistence, Latency, and Cure Approaches: Where Are We Now?","volume":"16","author":"TC Chou","year":"2024","journal-title":"Viruses"},{"issue":"11","key":"pgph.0004425.ref018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112303","article-title":"Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa","volume":"9","author":"EM Lazarus","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"pgph.0004425.ref019","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30069-2","article-title":"Evidence for HIV-1 cure after CCR5\u039432\/\u039432 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report","volume":"7","author":"RK Gupta","year":"2020","journal-title":"Lancet HIV"},{"issue":"3","key":"pgph.0004425.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(24)00002-X","article-title":"Call for justice-informed HIV cure trials with ATIs","volume":"11","author":"K Dub\u00e9","year":"2024","journal-title":"Lancet HIV"},{"issue":"1","key":"pgph.0004425.ref021","article-title":"Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US","volume":"3","author":"K Dub\u00e9","year":"2017","journal-title":"J Virus Erad"},{"issue":"1","key":"pgph.0004425.ref022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2055-6640(20)31148-1","article-title":"Recruitment and ethical considerations in HIV cure trials requiring treatment interruption","volume":"1","author":"MP Arnold","year":"2015","journal-title":"J Virus Erad"},{"key":"pgph.0004425.ref023","unstructured":"Human Sciences Research Council. Fifth South African national HIV prevalence, incidence, behaviour and communication survey (SABSSM V). 2017 [cited 2024 Aug 23] Available from: https:\/\/hsrc.ac.za\/uploads\/pageContent\/9234\/SABSSMV_Impact_Assessment_Summary_ZA_ADS_cleared_PDFA4.pdf"},{"key":"pgph.0004425.ref024","unstructured":"Statistics South Africa. Statistical release mid-year population estimates 2017. 2017 [cited 2024 Aug 26]. Available from: http:\/\/www.statssa.gov.za\/publications\/P0302\/P03022017.pdf"},{"issue":"10","key":"pgph.0004425.ref025","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1177\/1049732318821692","article-title":"What Influences Saturation? Estimating Sample Sizes in Focus Group Research","volume":"29","author":"MM Hennink","year":"2019","journal-title":"Qual Health Res"},{"issue":"5","key":"pgph.0004425.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232076","article-title":"A simple method to assess and report thematic saturation in qualitative research","volume":"15","author":"G Guest","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"pgph.0004425.ref027","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1753-6405.2007.00141.x","article-title":"Generating best evidence from qualitative research: the role of data analysis","volume":"31","author":"J Green","year":"2007","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"pgph.0004425.ref028","doi-asserted-by":"crossref","first-page":"100027","DOI":"10.1016\/j.jve.2020.100027","article-title":"Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research","volume":"7","author":"EY Bonney","year":"2021","journal-title":"J Virus Erad"},{"issue":"3","key":"pgph.0004425.ref029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229733","article-title":"The significance and expectations of HIV cure research among people living with HIV in Australia","volume":"15","author":"J Power","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"pgph.0004425.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202647","article-title":"Perceptions of HIV cure research among people living with HIV in Australia","volume":"13","author":"J Power","year":"2018","journal-title":"PLoS One"},{"key":"pgph.0004425.ref031","volume-title":"The Sixth South African National HIV Prevalence, Incidence and Behaviour Survey, 2022: A Summary Report","author":"K Zuma","year":"2024"},{"issue":"4","key":"pgph.0004425.ref032","first-page":"239","article-title":"Factors influencing non-adherence to antiretroviral therapy in South Africa: a systematic review. HIV & AIDS Review","volume":"18","author":"L Makhado","year":"2019","journal-title":"Int J HIV Relat Probl"},{"issue":"4","key":"pgph.0004425.ref033","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/09540121.2015.1112351","article-title":"HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives","volume":"28","author":"K Moodley","year":"2016","journal-title":"AIDS Care"},{"key":"pgph.0004425.ref034","doi-asserted-by":"crossref","first-page":"118161","DOI":"10.1016\/j.socscimed.2025.118161","article-title":"Corrigendum to \u201cEvaluating the psychosocial experiences of participants in HIV cure research before, during, and after analytical treatment interruptions: A longitudinal qualitative study in the United States\u201d [Soc. Sci. Med. Volume 366, February 2025, 117644]","volume":"381","author":"M Hill","year":"2025","journal-title":"Soc Sci Med"},{"issue":"1","key":"pgph.0004425.ref035","doi-asserted-by":"crossref","first-page":"100029","DOI":"10.1016\/j.jve.2021.100029","article-title":"Motivations, barriers and experiences of participants in an HIV reservoir trial","volume":"7","author":"M-A De Scheerder","year":"2021","journal-title":"J Virus Erad"},{"issue":"10","key":"pgph.0004425.ref036","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00267-0","article-title":"A partner protection package for HIV cure-related trials involving analytical treatment interruptions","volume":"23","author":"K Dub\u00e9","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pgph.0004425.ref037","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1186\/s12889-020-09785-0","article-title":"Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important","volume":"20","author":"F Laher","year":"2020","journal-title":"BMC Public Health"},{"issue":"2","key":"pgph.0004425.ref038","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0000000000000842","article-title":"A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies","volume":"71","author":"MJ Curno","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"pgph.0004425.ref039","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/QAD.0000000000003514","article-title":"Inclusion of women in HIV research and clinical trials","volume":"37","author":"CD Johnston","year":"2023","journal-title":"AIDS"},{"issue":"1","key":"pgph.0004425.ref040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12910-021-00651-1","article-title":"Ethics of HIV cure research: an unfinished agenda","volume":"22","author":"K Dub\u00e9","year":"2021","journal-title":"BMC Med Ethics"},{"issue":"4","key":"pgph.0004425.ref041","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(19)30052-9","article-title":"Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting","volume":"6","author":"B Julg","year":"2019","journal-title":"Lancet HIV"},{"issue":"1","key":"pgph.0004425.ref042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170112","article-title":"\u201cWell, It\u2019s the Risk of the Unknown\u2026 Right?\u201d: A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States","volume":"12","author":"K Dub\u00e9","year":"2017","journal-title":"PLoS One"},{"key":"pgph.0004425.ref043","doi-asserted-by":"crossref","first-page":"979756","DOI":"10.3389\/fmed.2022.979756","article-title":"Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption","volume":"9","author":"C-Y Lau","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"pgph.0004425.ref044","doi-asserted-by":"crossref","first-page":"2243046","DOI":"10.1080\/25787489.2023.2243046","article-title":"\u201cWith this study, we have hope that something is coming\u201d: community members\u2019 perceptions of HIV cure-related research in Durban, South Africa - a qualitative focus group study","volume":"24","author":"K Dub\u00e9","year":"2023","journal-title":"HIV Res Clin Pract"},{"issue":"6","key":"pgph.0004425.ref045","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1007\/s40615-023-01784-2","article-title":"Burnout Among Service Providers for People Living with HIV: Factors Related to Coping and Resilience","volume":"11","author":"R Reid","year":"2024","journal-title":"J Racial Ethn Health Disparities"},{"key":"pgph.0004425.ref046","doi-asserted-by":"crossref","first-page":"1220301","DOI":"10.3389\/fpubh.2023.1220301","article-title":"Workplace wellbeing among health care workers providing HIV services in primary care in Johannesburg: a mixed methods study","volume":"11","author":"N Makina-Zimalirana","year":"2023","journal-title":"Front Public Health"},{"issue":"8","key":"pgph.0004425.ref047","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/aid.2022.0040","article-title":"\u201cI Know That I Was a Part of Making a Difference\u201d: Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption","volume":"39","author":"R Neergaard","year":"2023","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"pgph.0004425.ref048","doi-asserted-by":"crossref","first-page":"100072","DOI":"10.1016\/j.jve.2022.100072","article-title":"Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection","volume":"8","author":"P van Paassen","year":"2022","journal-title":"J Virus Erad"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:38:27Z","timestamp":1762454307000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004425"}},"subtitle":[],"editor":[{"given":"Beryne","family":"Odeny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0004425","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}